Texas A&M University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Texas A&M University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013287
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Texas A&M University (TAMU) is a research based university that offers educational and research services. The university provides undergraduate, graduate and professional courses to its students. It consists of various colleges and departments such as College of Agriculture and Life Sciences, College of Architecture, Mays Business School, Baylor College of Dentistry, College of Education & Human Development, engineering students testing a robotic device, Dwight Look College of Engineering, College of Geosciences and College of Veterinary Medicine & Biomedical Sciences, among others. TAMU also provides education in the field of law, liberal arts, medicine, public health and science. The university offers undergraduate and graduate research programs. It operates in the US, Qatar, Mexico and Costa Rica. TAMU is headquartered in College Station, Texas, the US.

Texas A&M University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Texas A&M University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Texas A&M University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Texas A&M University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Texas A&M University and Greffex Sign Research Agreement 10
Texas A&M University Enters into Agreement with iBio 11
Licensing Agreements 12
Oragenics Amends Licensing Agreement with Texas A&M University System 12
Xoma Enters into Licensing Agreement with Texas A&M University System 14
Texas A&M University – Key Competitors 15
Texas A&M University – Key Employees 16
Texas A&M University – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Texas A&M University, Pharmaceuticals & Healthcare, Key Facts 2
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Texas A&M University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Texas A&M University, Deals By Therapy Area, 2011 to YTD 2017 8
Texas A&M University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Texas A&M University and Greffex Sign Research Agreement 10
Texas A&M University Enters into Agreement with iBio 11
Oragenics Amends Licensing Agreement with Texas A&M University System 12
Xoma Enters into Licensing Agreement with Texas A&M University System 14
Texas A&M University, Key Competitors 15
Texas A&M University, Key Employees 16
Texas A&M University, Other Locations 17
Texas A&M University, Subsidiaries 17

★海外企業調査レポート[Texas A&M University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wawa Inc:戦略・SWOT・企業財務分析
    Wawa Inc - Strategy, SWOT and Corporate Finance Report Summary Wawa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Jubilee Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    Jubilee Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Jubilee Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Almac Group Ltd:企業のM&A・事業提携・投資動向
    Almac Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Almac Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • PetroChina Co Ltd (857)-エネルギー分野:企業M&A・提携分析
    Summary PetroChina Company Limited (PetroChina), a subsidiary of China National Petroleum Corporation, is an oil and gas company that explores for, develops and produces crude oil and natural gas; refines crude oil and petroleum products; and produces and sells basic and derivative chemical products …
  • Xi’an Catering Co., Ltd.:戦略・SWOT・企業財務分析
    Xi'an Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Xi'an Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Archroma Pakistan Ltd. (ARPL):企業の財務・戦略的SWOT分析
    Archroma Pakistan Ltd. (ARPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • SkinMedica Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SkinMedica Inc (SkinMedica), a subsidiary of Allergan Plc, is a skin care service provider. The company offers cleanse, correct, moisturize and hydrate, protect, brighten, targeted treatments and professional peels among others. It provides essential serum, rejuvenating hydrator, total defen …
  • GNI Group Ltd (2160):企業の財務・戦略的SWOT分析
    Summary GNI Group Ltd (GNI) is a healthcare service provider that researches, develops, manufactures and markets pharmaceutical drugs. The company’s business operations consist of drug discovery activities such as drug discovery research, drug discovery infrastructure, fundamental drug discovery and …
  • Turk Hava Yollari Anonim Ortakligi:企業の戦略・SWOT・財務情報
    Turk Hava Yollari Anonim Ortakligi - Strategy, SWOT and Corporate Finance Report Summary Turk Hava Yollari Anonim Ortakligi - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Bank of Ayudhya Public Co Ltd (BAY):企業の財務・戦略的SWOT分析
    Bank of Ayudhya Public Co Ltd (BAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Nordea Private Banking:企業の戦略・SWOT・財務情報
    Nordea Private Banking - Strategy, SWOT and Corporate Finance Report Summary Nordea Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • NEC Corp (6701):企業の財務・戦略的SWOT分析
    NEC Corp (6701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Thrive Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Thrive Bioscience Inc (Thrive Bioscience) is a life science company that provides automated non-microbial cell culture instruments. The company’s cell culture systems provide scalable cell propagation, analytics, reproducible protocols, and complete process history documentation with the ima …
  • Ubisoft Entertainment SA (UBI):企業の財務・戦略的SWOT分析
    Ubisoft Entertainment SA (UBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • United Parcel Service Inc (UPS):企業の財務・戦略的SWOT分析
    United Parcel Service Inc (UPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • HomeWorks Tri-County Electric Cooperative Inc:企業の戦略的SWOT分析
    HomeWorks Tri-County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Eguana Technologies Inc. (EGT):企業の財務・戦略的SWOT分析
    Eguana Technologies Inc. (EGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Cardiac Dimensions Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cardiac Dimensions Inc (Cardiac Dimensions) is a medical equipment company that develops intervention tools used for treating heart failure and other related cardiovascular conditions. The company develops carillon mitral contour system, a coronary sinus-based percutaneous mitral annuloplast …
  • XBiotech Inc (XBIT):製薬・医療:M&Aディール及び事業提携情報
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed …
  • Canon Marketing Japan Inc (8060):企業の財務・戦略的SWOT分析
    Canon Marketing Japan Inc (8060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆